Log in

Relevant bibliographies by topics / Drugs; GPs / Books

To see the other types of publications on this topic, follow the link: Drugs; GPs.

Books on the topic 'Drugs; GPs'

Author: Grafiati

Published: 4 June 2021

Last updated: 2 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Drugs; GPs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Banks, A. Drug misuse: A practical handbook for GPs. Blackwell Scientific in association with the Institute for the Study of Drug Dependence, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Taulbee, Stephanie M. International GLPs in parallel: Taulbee's international pocket companion. Interpharm Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pfleger, Karl. Mass spectral and GC data of drugs, poisons, and their metabolites. VCH Verlagsgesellschaft, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Maurer, Hans. Mass spectral and GC data of drugs, poisons, pesticides, pollutants, and their metabolites. 3rd ed. VCH, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gross, David. Medicare beneficiaries and prescription drug coverage: Gaps and barriers. AARP, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kummerlowe, Dave. Hydrogen chloride gas generators associated with clandestine drug labs. Spills Program, Southwest Regional Office, Washington State Dept. of Ecology, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Gross, David. Medicare beneficiaries and prescription drug coverage: Gaps and barriers. AARP, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kummerlowe, Dave. Hydrogen chloride gas generators associated with clandestine drug labs. Spills Program, Southwest Regional Office, Washington State Dept. of Ecology, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Maurer, Hans. Mass spectral and GC data of drugs, poisons, pesticides, pollutants, and their metabolites. 4th ed. Wiley-VCH, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Closing the gaps in Hatch-Waxman: Assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002. U.S. G.P.O., 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Zeeuw, Rokus A. de. Gas chromatographic retention indices of toxicologically relevant substances on packed or capillary columns with dimethylsilicone stationary phases: Report XVIII of the DFG Commission for Clinical-Toxicological Analysis. 3rd ed. VCH, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Chappell, Colin Graham. Multidimensional liquid and gas chromatographic methods for veterinary drug analysis. University of East Anglia, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Chan, Kwai-Cheung. Over the counter drugs: Gaps and potential vulnerabilities in the regulatory system : statement of Kwai-Cheung Chan, Director of Program Evaluation in Physical Systems Areas, Program Evaluation and Methodology Division, before the Subcommittee on Regulation, Business Opportunities and Energy, Committee on Small Business, House of Representatives. The Office, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

International, Bioanalytical Forum (7th 1987 Guildford England). Bioanalysis of drugs and metabolites, especially anti-inflammatory and cardiovascular. Plenum Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

United States. Food and Drug Administration. The Food and Drug Administration's good laboratory practice for nonclinical laboratory studies (GLPs). 3rd ed. Keystone Press, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Administration, United States Food and Drug. The Food and Drug Administration's good laboratory practice for nonclinical laboratory studies (GLPs). 4th ed. Keystone Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. FDA user fees 2012: Issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012. U.S. Government Printing Office, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Karl, Pfleger. Mass spectral and GC data of drugs, poisons, pesticides, pollutants, and their metabolites. 2nd ed. VCH, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Laroussi, M. Plasma medicine: Applications of low-temperature gas plasmas in medicine and biology. Cambridge University Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

A chance to win: Boyhood, baseball, and the struggle for redemption in the inner city. Henry Holt and Co., 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

United States. Dept. of Transportation. Research and Special Programs Administration. Pipeline safety regulations: Enforcement procedures part 190, natural gas parts 191-192, liquefied natural gas part 193, oil pipelines response plans part 194, hazardous liquids part 195, state grants part 198, drug testing part 199. U.S. G.P.O., 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Administration, United States Pipeline and Hazardous Materials Safety. Pipeline safety regulations: Enforcement procedures part 190, natural gas parts 191-192, liquefied natural gas part 193, oil pipelines response plans part 194, hazardous liquids part 195, state grants part 198, drug testing part 199. U.S. G.P.O., 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Chu-sgaṅ Sa-ʼdu brgya dpoṅ Tre-hor dkar mdzes Gtsaṅ-kha-tshaṅ Bstan-pa-dar-rgyas kyi mi tshe lo rgyus: Dmag ʼkhrug gis bskyel baʼi mi tshe : ra smad gru kha. Sonam Dorjee, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

United States. Congress. House. Committee on Merchant Marine and Fisheries. Subcommittee on Coast Guard and Navigation. Maritime and offshore drilling industry drug testing: Hearing before the Subcommittee on Coast Guard and Navigation of the Committee on Merchant Marine and Fisheries, House of Representatives, one hundred first Congress, second session on recent drug testing regulations adopted by the Department of Transportation for the maritime and offshore industry, June 26, 1990. U.S. G.P.O., 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

The administration's prescription drug proposal: Hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Sixth Congress, second session, May 11, 2000. U.S. G.P.O., 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Office, General Accounting. Defense inventory: Gaps in accountability and visibility over army missiles and ammunition : report to the ranking minority member, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate. U.S. General Accounting Office, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

King, Stephen. Night Shift. New American Library, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

King, Stephen. Night shift. ISIS Large Print, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

King, Stephen. El umbral de la noche. Plaza y Janés, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

King, Stephen. Night shift. G.K. Hall, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

King, Stephen. Night Shift. New English Library, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

King, Stephen. Night Shift. New American Library, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

King, Stephen. Night shift. Anchor Books, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

King, Stephen. Night Shift. Knopf Doubleday Publishing Group, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

King, Stephen. Night Shift. Anchor Books, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Li, Jie Jack. Laughing Gas, Viagra, and Lipitor. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195300994.001.0001.

Full text

Abstract:

The stories behind drug discovery are fascinating, full of human and scientific interest. This is a book on the history of drug discovery that highlights the intellectual splendor of discoverers as well as the human frailty associated them. History is replete with examples of breakthrough medicines that have saved millions of lives. Ether as an anesthetic by Morton; penicillin as an antibiotic by Fleming; and insulin as an anti-diabetic by Banting are just a few examples. The discoverers of these medicines are doubtlessly benefactors to mankind--for instance, without penicillin, 75% of us prob

APA, Harvard, Vancouver, ISO, and other styles

37

Waldmann, Carl, Neil Soni, and Andrew Rhodes. Respiratory drugs. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199229581.003.0010.

Full text

Abstract:

Bronchodilators 154Nitric oxide 156Mucolytics 158Surfactant 160Helium–oxygen gas mixtures 162Bronchodilators, as the name suggests, are used in airways disease, particularly in asthma and COPD, to produce a reversal of airway obstruction. An overview of the three main categories is provided here:...

APA, Harvard, Vancouver, ISO, and other styles

38

International Drug Gmps. 4th ed. Interpharm Pr, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Wilson, Joanna, and Ben Ballisat. Drug formulary. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198719410.003.0043.

Full text

Abstract:

This chapter provides a drug formulary which is pertinent to the anaesthetist. Adult and paediatric doses of over a hundred drugs are provided, and a series of infusion regimes is presented. The chapter concludes with a table of medical gas cylinders and their contents, a table of minimum alveolar concentration values, and a discussion of antibiotic prophylaxis.

APA, Harvard, Vancouver, ISO, and other styles

40

Banks, A., and T. A. N. Waller. Drug Misuse: A Practical Handbook for Gps. Year Book Medical Pub, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kinner, Stuart A,, and Josiah D. Jody Rich, eds. Drug Use in Prisoners. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.001.0001.

Full text

Abstract:

The majority of people who experience incarceration have a history of harmful alcohol, tobacco, and/or illicit drug use. Some discontinue use of these substances while in custody. Others—notably including some people who inject drugs—continue to use drugs in prison, typically in avoidably high-risk circumstances. Rapid relapse to risky substance use after release from prison is common and is associated with a range of health and social problems, and increased risk of both death and reincarceration. Effective measures to reduce the incarceration of people who use drugs, and to minimize drug-rel

APA, Harvard, Vancouver, ISO, and other styles

42

Warnock, David W. Introduction to medical mycology. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0001.

Full text

Abstract:

The pattern of fungal diseases has changed with the emergence of new pathogens and the resurgence of old ones. Many factors have contributed to this, including medical progress, environmental changes, and the development of drug resistance. The impact of these diseases on human health is not widely recognized, largely because of the many gaps in epidemiological surveillance data. Access to affordable diagnostics and antifungal drugs are critical issues in the developing world. New approaches to prevention and control will be needed if we are to reduce the substantial global burden of ill healt

APA, Harvard, Vancouver, ISO, and other styles

43

Li, Jie Jack. Laughing Gas, Viagra, and Lipitor: The Human Stories behind the Drugs We Use. Oxford University Press, USA, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Small, Will, and Ryan McNeil. Understanding the Risk Environment Surrounding Drug Use in Prisons. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0011.

Full text

Abstract:

Qualitative research is uniquely positioned to advance understanding of the role of social and structural factors in shaping drug use and drug-related harms in prison settings and following release. This chapter critically reviews the qualitative literature examining drug use within the prison risk environment and following release, while identifying research gaps and directions for future inquiry. The extant literature has documented: (1) how drug use in prisons is shaped by which drugs are available, their pharmacological effects, and correctional policies; (2) how injection-related risk and

APA, Harvard, Vancouver, ISO, and other styles

45

Pfleger, Karl, Hans H. Maurer, and Armin Weber. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites. 3rd ed. Wiley-VCH, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Taxman, Faye S., and Mary Mun. Recidivism. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0013.

Full text

Abstract:

High rates of rearrest and recidivism, especially among drug-involved individuals, are of grave concern for the justice system and society at large. This chapter looks at the factors affecting recidivism rates of substance-involved individuals involved in the justice system. We begin by considering the complexity of measuring recidivism and the meaning of this concept; the term is fraught with difficulties due to the complexities of generalizing findings across studies with varying sampling frames and time-frames for follow-up, and differences in the types of recidivism events studied. Recent

APA, Harvard, Vancouver, ISO, and other styles

47

A, De Zeeuw R., Deutsche Forschungsgemeinschaft, and International Association of Forensic Toxicologists. Committee for Systematic Toxicological Analysis., eds. Gas chromatographic retention indices of toxicologically relevant substances on packed or capillary columns with dimethylsilicone stationary phases. 3rd ed. VCH Verlagsgesellschaft, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Nageshwaran, Sathiji, Heather C. Wilson, Anthony Dickenson, and David Ledingham. Disorders of peripheral nerves and motor neuron disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199664368.003.0007.

Full text

Abstract:

This chapter discusses the clinical features and evidence-based drug treatment regimens of polyneuropathies (Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy, paraproteinaemic neuropathies, and vasculitic neuropathies), mononeuropathies (Bell’s palsy), systemic conditions with peripheral nerve involvement (Sjögren’s and sarcoidosis), and motor neuron disease (MND).

APA, Harvard, Vancouver, ISO, and other styles

49

1922-, Reid Eric, Robinson J. D, Wilson Ian D, and International Bioanalytical Forum, (7th : 1987 : Guildford, England), eds. Bioananlysis of drugs and metabolytes: Especially anti-inflammatory and cardiovascular. Plenum Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Wiffen, Philip, Marc Mitchell, Melanie Snelling, and Nicola Stoner. Pharmaceutical calculations. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199603640.003.0012.

Full text

Abstract:

Concentrations 236Moles and millimoles 238Practical issues involving pharmaceutical calculations 240Pharmaceutical calculations involving drug administration 242Pharmaceutical preparations consist of a number of different ingredients in a vehicle. The ingredients can be solid, liquid, or gas.‘Concentration’ is an expression of the ratio of the amount of an ingredient to the amount of product. Concentrations can be expressed in several ways. ...

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!